These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3032326)

  • 21. Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study.
    MacGregor GA; Markandu ND; Singer DR; Cappuccio FP; Shore AC; Sagnella GA
    Br Med J (Clin Res Ed); 1987 Feb; 294(6571):531-4. PubMed ID: 3103761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale for the choice of antihypertensive agents.
    Muiesan G
    J Clin Hypertens; 1986 Jun; 2(2):189-94. PubMed ID: 2876062
    [No Abstract]   [Full Text] [Related]  

  • 23. [Inhibitors of angiotensin-converting enzyme in the treatment of arterial hypertension].
    Salvetti A; Pedrinelli R; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Cardiologia; 1984; 29(1-2):103-20. PubMed ID: 6085475
    [No Abstract]   [Full Text] [Related]  

  • 24. Failure of chronic administration of the angiotensin I-converting enzyme inhibitor, Teprotide (SQ 20881), to affect the ultrastructure of the adrenal cortex and the aldosterone secretion in the rat.
    Weaver J; Nickerson PA; Molteni A; Solliday N; Albertson D
    Lab Invest; 1981 Dec; 45(6):527-33. PubMed ID: 6172661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Converting enzyme inhibition: implications for renal perfusion and function.
    Hollenberg NK
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():73-9. PubMed ID: 6183037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy of hypertensive heart disease: vasodilator agents in the forefront].
    Bolli P; Bühler FR
    Ther Umsch; 1984 Feb; 41(2):150-5. PubMed ID: 6200947
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibitors of the renin-angiotensin system. Effects on blood pressure, aldosterone secretion and renal function.
    Atlas SA; Niarchos AP; Case DB
    Am J Nephrol; 1983; 3(2-3):118-27. PubMed ID: 6191567
    [No Abstract]   [Full Text] [Related]  

  • 28. Angiotensin converting enzyme inhibitors: drug interactions.
    Hodsman GP; Johnston CI
    J Hypertens; 1987 Feb; 5(1):1-6. PubMed ID: 3035008
    [No Abstract]   [Full Text] [Related]  

  • 29. [Calcium channel blockers and angiotensin converting enzyme inhibitors in the treatment of high blood pressure].
    Koster M
    Ned Tijdschr Geneeskd; 1986 Aug; 130(34):1509-13. PubMed ID: 3020442
    [No Abstract]   [Full Text] [Related]  

  • 30. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
    Laragh JH; Case DB; Wallace JM; Keim H
    Fed Proc; 1977 Apr; 36(5):1781-7. PubMed ID: 191300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin converting enzyme inhibition: a new therapeutic modality.
    Gavras H; Charocopos F; Brunner H; Gavras I
    Bull N Y Acad Med; 1981 May; 57(4):304-10. PubMed ID: 6164426
    [No Abstract]   [Full Text] [Related]  

  • 32. Demonstration of a primary antidiuretic action of angiotensin II: effects of intrarenal converting enzyme inhibition in the conscious dog.
    Levens NR; Peach MJ; Vaughan ED; Carey RM
    Endocrinology; 1981 Jan; 108(1):318-30. PubMed ID: 6161801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure elucidation of angiotensin converting enzyme inhibitor L-681,176 from Streptomyces sp. MA 5143a.
    Hensens OD; Liesch JM
    J Antibiot (Tokyo); 1984 May; 37(5):466-8. PubMed ID: 6203887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the effects of two angiotensin converting enzyme inhibitors, SQ 14 225 and MK 422 in Na-restricted sheep.
    Nelson MA; Stewart KW; Coghlan JP; Denton DA; Fei DT; Scoggins BA
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():87-91. PubMed ID: 6183038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system.
    Kondo K; Kida O; Kodama K; Higa T; Someya N; Morotomi Y; Tanaka K
    Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):337-42. PubMed ID: 2991635
    [No Abstract]   [Full Text] [Related]  

  • 36. Angiotensin converting enzyme inhibitors in the treatment of hypertension.
    Materson BJ
    Compr Ther; 1983 Oct; 9(10):14-20. PubMed ID: 6196149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-dependent hypertension--potential pitfalls in definition.
    Williams GH
    N Engl J Med; 1977 Mar; 296(12):684-5. PubMed ID: 190538
    [No Abstract]   [Full Text] [Related]  

  • 38. [Angiotensin II inhibitors for the diagnosis and treatment of hypertension].
    Brunner HR; Gavras H
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1791-8. PubMed ID: 1013701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of specific angiotensin inhibitors in the diagnosis and treatment of arterial hypertension].
    Novikova LS; Arabidze GG
    Ter Arkh; 1979; 51(5):99-108. PubMed ID: 222004
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of angiotensin converting enzyme inhibitor on cardiovascular response to lower body negative pressure [proceedings].
    Adigun SA; Clough D; Conway J; Hatton R
    J Physiol; 1980 Jan; 298():30P-31P. PubMed ID: 6153719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.